Snowball logo
logo
0869

Medy-Tox Inc

086900 KQ
76,800.000.00  (0%)
Estimate
Beta
0.412
Growth
Revenue, YoY
-5.11%
Net income, YoY
104.88%
FCF, YoY
89.12%
Forecast
P/E (FWD)
12.6
EPS (FWD)
6,101.159
Dividends
Dividend yield
1.56%
Annual payout
1,200.00
Next ex. div date
September 29, 26
Payout
53.75%
Div.growth, 5y
6.79%
Dividend growth streak
1 year
Div.rating
About the company
Ticker
086900
ISIN
KR7086900008
Country
South Korea
Sector (GICS)
Healthcare
Medy-Tox Inc. operates as a biopharmaceutical company in South Korea. It provides botulinum toxin products, including Neuronox, a lyophilized white power for injection that is used to treat foot deformities due to spasticity in pediatric cerebral palsy patients; INNOTOX, a colorless transparent liquid-filled injection that is used to temporarily improve moderate to severe glabellar wrinkles; and Coretox, a lyophilized white power for injection that is used to temporarily improve moderate to severe glabellar wrinkles. The company also offers hyaluronic acid filler products comprising Neuramis and Potenfill that are tissue recovering biomaterials. In addition, it provides various medical devices, such as ComfortDual for tissue coagulation by using high-frequency current; Neurajet Plus to assist injecting other pharmaceuticals; and Carewave for improving erectile dysfunction by using low-intensity shock wave generated from the electromagnetic method. It also exports its products to approximately 60 countries, including Japan, Brazil, and internationally. Medy-Tox Inc. was founded in 2000 and is headquartered in Cheongju, South Korea.

Frequently asked questions

What sector does Medy-Tox Inc (086900) operate in?

Medy-Tox Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is Medy-Tox Inc (086900) current stock price?

As of the latest data, Medy-Tox Inc stock price is ₩76,800, with a previous close of ₩76,800.

What is Medy-Tox Inc (086900) current market capitalization?

Medy-Tox Inc market cap is approximately 500.55 billion.

Does Medy-Tox Inc (086900) pay dividends?

Yes. Medy-Tox Inc pays annual dividends with an annualized yield of 1.56% and an estimated annual payout of ₩1,200 per share.

When is the next ex-dividend date for Medy-Tox Inc (086900)?

The next ex-dividend date is scheduled for September 29, 2026.

How did Medy-Tox Inc (086900) perform in its most recent earnings report?

In the last report (March 31, 2026), Medy-Tox Inc posted an EPS surprise of 115.2% and a revenue surprise of -12.74%.

What is Medy-Tox Inc (086900) beta (volatility) score?

Medy-Tox Inc has a beta of 0.412, indicating lower volatility than the overall market.